---
schema_version: "secwatch.filing_event.v1"
accession: "0001606498-23-000039"
form_type: "8-K"
ticker: "AVNS"
cik: "0001606498"
company_name: "AVANOS MEDICAL, INC."
filed_at: "2023-05-03T23:59:59+00:00"
generated_at: "2026-06-16T01:06:05.585020+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "medium"
source: SEC EDGAR
---

# Avanos Medical reports Q1 results and holds annual meeting; all proposals approved

## Summary
- Q1 2023 earnings released May 3, 2023; no financial figures provided in the filing.
- Annual meeting held Apr 27, 2023; 94.23% of shares represented (43,916,111 shares).
- All six director nominees elected; Dr. Julie Shimer received lowest support (35.5M for, 6.2M withheld).
- Delaware auditor ratified (43.5M for, 0.27M against); advisory say-on-pay approved (38.96M for, 2.59M against).
- LTIP amended to increase authorized shares by 1.25M (39.96M for, 1.59M against).

## SEC filing metadata
- accession: 0001606498-23-000039
- form_type: 8-K
- ticker: AVNS
- cik: 0001606498
- company_name: AVANOS MEDICAL, INC.
- filed_at: 2023-05-03T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: medium
- sec_items: 2.02, 5.07, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1606498/000160649823000039/0001606498-23-000039-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1606498/000160649823000039/avns-20230427.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001606498-23-000039
- JSON: https://secwatch.observer/filing/0001606498-23-000039.json
- Plain text: https://secwatch.observer/filing/0001606498-23-000039.txt

## Key facts
- Earnings Releases
  AVANOS MEDICAL, INC. reported financial results for the three months ended March 31, 2023.
  - Period: the three months ended March 31, 2023
  - Result: reported results
  source text: Avanos Medical, Inc. (the “Company”) announced its results of operations for the three months ended March 31, 2023 in a press release dated May 3, 2023.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1606498/000160649823000039/0001606498-23-000039-index.htm
- Shareholder Votes
  AVANOS MEDICAL, INC. shareholders approved Approve an amendment to the Company’s 2021 Long Term Incentive Plan to increase the number of shares reserved for issuance at the 2023-04-27 meeting.
  - Proposal: equity plan
  - Outcome: passed
  - Meeting: 2023-04-27
  source text: The votes cast on Proposal No. 4 were as follows: For Against Abstain Broker non-votes Amendment of the 2021 Long Term Incentive Plan 39,961,025 1,585,386 112,920 2,256,780
  evidence_url: https://www.sec.gov/Archives/edgar/data/1606498/000160649823000039/0001606498-23-000039-index.htm
- Shareholder Votes
  AVANOS MEDICAL, INC. shareholders approved Ratify the appointment of Deloitte & Touche LLP as the Company’s independent auditors for 2023 at the 2023-04-27 meeting.
  - Proposal: auditor ratification
  - Outcome: passed
  - Meeting: 2023-04-27
  source text: The votes cast on Proposal No. 2 were as follows: For Against Abstain Appointment of Deloitte & Touche LLP 43,502,269 268,752 145,090
  evidence_url: https://www.sec.gov/Archives/edgar/data/1606498/000160649823000039/0001606498-23-000039-index.htm
- Shareholder Votes
  AVANOS MEDICAL, INC. shareholders approved Approval, on an advisory basis, of the compensation of the Company’s named executive officers at the 2023-04-27 meeting.
  - Proposal: say on pay
  - Outcome: passed
  - Meeting: 2023-04-27
  source text: The votes cast on Proposal No. 3 were as follows: For Against Abstain Broker non-votes Approval of NEO compensation 38,956,746 2,593,580 109,005 2,256,780
  evidence_url: https://www.sec.gov/Archives/edgar/data/1606498/000160649823000039/0001606498-23-000039-index.htm
- Shareholder Votes
  AVANOS MEDICAL, INC. shareholders approved Election of directors at the 2023-04-27 meeting.
  - Proposal: director election
  - Outcome: passed
  - Meeting: 2023-04-27
  source text: The votes cast on Proposal No. 1 were as follows: Director For Withhold Broker non-votes Gary D. Blackford 40,939,693 719,638 2,256,780 John P. Byrnes 41,020,988 638,343 2,256,780 Dr. Lisa Egbuonu-Davis 41,187,183 472,148 2,256,780 Patrick J. O’Leary 41,327,319 332,012 2,256,780 Dr. Julie Shimer 35,455,820 6,203,511 2,256,780 Joseph F. Woody 41,422,567 236,764 2,256,780
  evidence_url: https://www.sec.gov/Archives/edgar/data/1606498/000160649823000039/0001606498-23-000039-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.